EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome

Liang Zhang, Xue Ni, Minzhi Jiang iD, Mengxuan Du, Shuwen Zhang, He Jiang, Chang Liu, Shuangjiang Liu iD

Microorganisms · 27.05.2024 · 12 (6) · 1081

DOI: 10.3390/microorganisms12061081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 27.05.2024. Verfasst von Liang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, WONDERLAB Innovation Centre for Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lacticaseibacillus rhamnosus is applied as a probiotic to alleviate various metabolic, gastrointestinal, and psychological symptoms and diseases, and its probiotic effectiveness is strain-specific. In this study, we obtained 21 strains of Ls. rhamnosus, and their genomes were sequenced. We defined the pan- and core-genomes of Ls. rhamnosus. Phenotypes such as the assimilation of carbohydrates and antibiotic resistance were experimentally characterized and associated with genome annotations. Nine strains were selected and tested for growth rates, tolerance to acidity/alkalinity and bile acids, the production of short-chain fatty acids, and competition with pathogenic microbes. Strains WL11 and WL17 were targeted as potential probiotics and were applied in mouse model tests for the alleviation of chronic fatigue syndrome (CFS) and irritable bowel syndrome (IBS). The results showed that WL11 and WL17 effectively alleviated slow body weight gain, anxiety, poor memory, and cognitive impairment in CFS mouse models. They also reduced the expression of pro-inflammatory factors, such as TNF-α and IL-6, and alleviated intestinal peristalsis, visceral hypersensitivity, and anxiety-like behavior in IBS mouse models. This study reports new Ls. rhamnosus strain resources and their effect on alleviation of both IBS and CFS symptoms with mouse models; the probiotic functions of those strains in human patients remain to be further tested.

Schlagwörter

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosuschronic fatigue syndrome (CFS)irritable bowel syndrome (IBS)metabolic and genetic diversitypan- and core-genomesstrain-specific probiotics

Autor:innen und Institutionen

  • State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
  • State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

ORCID-Profile: Minzhi Jiang, Shuangjiang Liu

Förderung

  • National Natural Science Foundation of China
  • WONDERLAB Innovation Centre for Healthcare

Zitieren

APA

Zhang, L., Ni, X., Jiang, M., Du, M., Zhang, S., Jiang, H., Liu, C., & Liu, S. (2024). Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome. Microorganisms, 12(6), 1081. https://doi.org/10.3390/microorganisms12061081

Vancouver

Zhang L, Ni X, Jiang M, Du M, Zhang S, Jiang H, et al. Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome. Microorganisms. 2024;12(6):1081. doi:10.3390/microorganisms12061081

BibTeX
@article{Zhang2024,
  author = {Zhang, Liang and Ni, Xue and Jiang, Minzhi and Du, Mengxuan and Zhang, Shuwen and Jiang, He and Liu, Chang and Liu, Shuangjiang},
  title = {Lacticaseibacillus rhamnosus Strains for Alleviation of Irritable Bowel Disease and Chronic Fatigue Syndrome},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {6},
  pages = {1081},
  doi = {10.3390/microorganisms12061081}
}
Kostenlos starten →